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"There is only one duty, only one safe 
course, and that is to try to be right". 
- Sir Winston Churchill 
Colleagues: 
April is here and with it Springtime. As I sit 
writing this today the weather is beautiful, and 
it appears that Spring is really approaching. I 
hope you've all had a good month of March. 
I'm sure that all of you share with me in 
expressing our deep and heartfelt 
condolences and sympathy to Ed and Pat 
Mullin and their family upon the recent death 
of their daughter, Susan. Susan died 
suddenly on March 16 after a long battle with 
cystic fibrosis. 
My first Medical Staff meeting as your 
President on March 8, 1999 was held at the 
Banko Center on the Muhlenberg Hospital 
Center campus. The meeting was well 
attended. In addition to the usual agenda 
items, Dr. Greg Harper made a presentation 
about the vision and goals of the John & 
Dorothy Morgan Cancer Center. This 
presentation was well received and numerous 
important questions were addressed to Greg. 
John Haney and Dr. Robert Murphy made a 
presentation at the meeting about compliance 
related to billing and the Federal 
Government's initiative to investigate private 
physicians' office billing practices to detect 
Medicare fraud and abuse. There are serious 
implications for all physicians relative to this 
matter. We all need to be sensitive to these 
issues and be very careful in our billing 
(Continued on Page 2) 
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practices to insure that we are in compliance with Medicare 
guidelines. A documented process needs to be outlined in 
each practice office to deal with billing errors and 
complaints. John Haney and Lehigh Valley Physician 
Business Services has already provided a seminar to help 
physicians and their office staffs deal with and understand 
these issues. This seminar will be repeated in the:Fall. 
Any physicians, office managers, or billing personnel 
interested in a future seminar should contact Lehigh Valley 
Physician Business Services at (610) 317-4440. 
Dr. John Jaffe, co-chair of the Care Management Council, 
made a presentation updating the members of the medical 
staff about the activities of the Care Management Council 
and plans for the reorganized Care Management 
Committee. I have asked either John or Bob Laskowski 
(the other co-chair) to make a report to the Medical 
Executive Committee each month. I will also ask one of 
them to make a brief presentation at each of the quarterly 
General Medical Staff meetings. There are many care 
management issues which need to be addressed by each 
of us in our daily practices both in and outside the hospital. 
How can we provide the highest level of quality care for our 
patients more efficiently, at a lower cost, and in a shorter 
length of time? Our nursing colleagues have been 
particularly stressed over the last few months as the 
hospital has been extremely busy. Much of the stress they 
feel is related to the things we ask them to do for our 
patients. Remember, we need to think about ways in which 
we can "take work out of the system" every day. Is the 
result of the lab test or x-ray study which I am ordering 
really going to change the way I manage this patient? If 
the answer is "No", don't order the test. Does what I am 
doing for my patient today require that he or she be in the 
hospital, or could the patient receive the same care in 
some other setting which would be less expensive, just as 
effective, and perhaps even more satisfying for the patient? 
If inpatient care isn't required, ask the discharge planner to 
help get the patient into whatever setting seems more 
appropriate. 
Speaking of our nursing colleagues, I'd like to personally 
thank them for their outstanding service to our patients over 
the past several months when the hospital has been 
stressed by high census, bed shortages, and rapid patient 
turnover. We appreciate your tireless efforts as well as 
those of the technical, support, and administrative partners 
in providing high quality, compassionate care to our 
patients through a very difficult period. As we make our 
rounds on the hospital floors, we all need to remember to 
thank our nursing colleagues for their tremendous help. 
"Thanks again." 
( 
On March 10, I chaired a Medical Staff/Administrative 
exchange session held to address issues related to the 
operation of the operating rooms at Lehigh Valley Hospital, 
Cedar Crest & 1-78. A large group of interested surgeons 
attended this meeting and offered a number of excellent 
suggestions. Drs. Chuck Hoover and Mark Lester, and Mr. 
Lou Liebhaber (COO), described the plans which are 
underway to improve the functioning of the operating 
rooms, answered questions, and listened to suggestions. I 
believe that this meeting was useful and, hopefully as a 
result, some immediate actions will be taken to improve the 
overall efficiency of the functioning of the operating rooms. 
I've recently met with Ed Meehan, MPH, Executive 
Director, and Courtney J. Brown, MPH, Program Officer, 
from the Dorothy Rider Pool Health Care Trust. The Pool 
Trust is anxious to provide funding grants for projects which 
will improve the general health of the Lehigh Valley 
community. They have asked me to encourage interested 
members of the Medical Staff who have ideas for 
interesting proposals to contact Courtney at (610) 770-9346 
to discuss their ideas. Administrative help is available to 
develop grant request proposals. I have asked Ed to cor-
to the June General Medical Staff Meeting to make a ( 
presentation about the Pool Trust, and to again remind the 
Medical Staff that Mr. Pool set aside a great deal of money 
to fund projects for the improvement of the health of our 
community. I'm sure that many of us can think of some 
project which would qualify for this laudable goal and is 
only in need of adequate funding. The message is that 
there is funding available; we just need to ask for it. 
Remember to appoint someone from your office as your 
"surrogate" to read your e-mail, if you aren't a regular user 
of e-mail. Also remember when you round daily on your 
hospital patients to: S.A. T. ("Sit, Ask/Answer, and 
Touch"). 
In closing, Winston Churchill advises that the one duty and 
one course is to try to be right. I can't promise that I will 
always be right, but I will try, and I will try to do the right 
thing for our Medical Staff. 
&~ 
David M. Caccese, MD 
Medical Staff President 
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At-Large Members Needed for L VH 
Medical Executive Committee 
The Lehigh Valley Hospital Medical Staff Nominating 
Committee is soliciting nominations for five at-large seats, 
one of which should be a representative whose primary 
clinical practice is based at the Muhlenberg Hospital Center 
campus. These at-large seats on the Medical Executive 
Committee will be held for a three-year term beginning July 
1' 1999. 
Nominations should be submitted in writing to Edward M. 
Mullin, Jr., MD, Chainnan of the Nominating Committee, via 
the Medical Staff Services Office, Cedar Crest & 1-78, or 
verbally to John W. Hart, Vice President. All nominations 
must be submitted by Friday, April30, 1999. 
If you have any questions regarding this issue, please 
contact Dr. Mullin or Mr. Hart at 402-8980. 
Washington!AMA Update 
The political heat is, once again, being turned up on 
( medicine in Washington. Faced with the prospect of saving 
.. Medicare and the Social Security system in a political 
climate that will not tolerate increasing the burden of 
taxpayers, the political leadership in our nation's capital is 
attempting to find ways to generate new dollars. Their 
strategy is a two-pronged attack on physicians in this 
country. 
( 
1) Cut cost. The simple solution is to pay fewer dollars to 
those who provide medical care. In 1997, the Heatth Care 
Financing Administration (HCFA) adopted new Evaluation 
and Management (E&M) guidelines. This policy assigned 
levels of care, and thus reimbursement, to a "counting" 
system in which an increasing number of systems would be 
required to be examined and documented to qualify for a 
higher level of care. Furthermore, physicians whose 
practices were deemed to be non-compliant with these 
guidelines would be considered potential guilty of criminal 
fraud and abuse. The AMA was able to delay institution of 
these guidelines from the proposed date of July 1, 1998. 
HCFA has recently informed the AMA that, although it is 
willing to work together with the AMA and its CPT Editorial 
Panel to minimize counting requirements and to otherwise 
simplify and improve the guidelines, some degree of 
"counting" is necessary to achieve consistency of Medicare 
carrier enforcement policies. 
HCFA has also emphasized that, in the current 
environment, prepayment audits would not be discontinued 
and that review by physicians only was not an option that it 
would consider. They also emphasized that their focus 
was not on one-level disagreements in coping. The AMA 
has advocated that, given HCFA's focus on differences of 
more than one level, the guidelines should not be designed 
with higher precision than needed by reviewers to fair1y 
assess the level of service provided. 
Based on the fact that HCFA would not rule out counting, 
and after many hours of careful consideration and 
consultation with leaders of organized medicine, the Board 
concluded that physicians would be best served if it asked 
the AMA's CPT Editorial Panel to resume work with HCFA 
on the E&M documentation guidelines in order to minimize 
physicians' documentation burden, even though HCFA will 
not eliminate counting. This participation is premised on 
the understanding that any resulting documentation 
guidelines will be HCFA's guidelines. 
As it resumes work on the guidelines, the CPT Editorial 
Panel has been asked to focus on efforts: 
• to ensure that any guidelines are as consistent as 
possible with CPT definitions; and 
• to diminish the role of "counting" in any guidelines to 
the greatest degree possible. 
The AMA has continued to work with HCFA and the 
Federation on other important AMA policies from A-98 in 
areas such as fraud and abuse, confidentiality, medical 
review, working with state medical associations to pilot 
peer review approaches to E&M services, the need to 
obtain informed consent on release of medical records, and 
physician education. 
The AMA does not expect that any resulting guidelines will 
be implemented by HCFA before late in 1999 at the 
ear1iest. In the meantime, physicians must also keep in 
mind that HCFA's current policy requires physicians to 
comply with either the 1995 documentation guidelines or 
the 1997 version. 
2) Increase income. If the Federal Government can't get 
money from the taxpayers, they are going to try to get it 
from the doctors. Many of you will recall the penalties paid 
by large teaching hospitals in Philadelphia to the 
government related to disputed billing practices. This 
proved to be such a windfall for the government that it 
decided to extend this approach to the physicians 
(Continued on Page 4) 
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themselves. The Federal Government has, therefore, 
budgeted $500 million over the next five years for a 
program which will empower the Office of the Inspector 
General (OIG) to hire additional inspectors whose sole 
purpose will be to invade doctors' offices to examine 
patient and financial records so that deviations from 
governmental interpretations can be documented and 
fines assessed. In the few months that this program has 
existed, fines levied against physician practices have 
been as high as $500,000 to $1 ,000,000! 
So, I appeal to each and every one of my physician 
colleagues to begin to prepare for this onslaught. With 
regard to new E&M guidelines, stand ready to heed any 
call to action made by the AMA in the months to come. 
When faced with this new initiative by the OIG, we must 
be more proactive and prepared. I urge every one of us 
to establish an office compliance program and make 
ready for the invasion of the Visigoths. 
Perhaps in no other more immediate way can value be 
seen in being members of our GLVIPA and PHO than in 
a service which is being offered that can help us meet 
this onslaught. Mr. John Haney, Executive Director, 
Lehigh Valley Physician Business Services (LVPBS), is 
offering, through the MSO, courses and consultation. 
LVPBS can assist you and your staff in creating a 
compliance program that ensures the practice's intent 
and commitment to comply with all Medicare, Medicaid, 
and managed care rules. Developing a voluntary plan 
will help avoid prosecution, discourage wrongdoing, and 
detect problems before they escalate out of control. For 
more information, please contact Mr. Haney at (610) 
317-4441. 
Please, be prepared! 
Robert X. Murphy, Jr., MD 
OMSS Representative 
Lehigh Valley Hospital 
Rapid HIV Test 
Effective March 9, Rapid HIV Tests will be utilized wht., 
a healthcare worker has a significant occupational 
exposure to a patient's blood or body fluids. Rapid 
resulting of both the healthcare worker's and the source 
patient's HIV status will assist in providing appropriate 
post-exposure management, which is an important 
element of workplace safety. 
If a source patient is HIV positive, post-exposure 
prophylaxis (one or more medications) may be helpful in 
preventing the transmission of the HIV virus to the 
exposed healthcare worker. The medication should be 
started within hours of the exposure. In order to take 
advantage of the rapid testing, it is crucial that any 
health care worker who experiences a blood or body 
fluid exposure report the exposure immediately to 
Employee Health Services during business hours 
(Monday through Friday, 7:30 a.m. to 4 p.m.). If an 
exposure occurs evenings or nights, holidays or 
weekends, the exposed healthcare worker should 
report directly to the Emergency Department with 
his/her incident report. 
Please take advantage of this new technology which J ...
result in improved post-exposure management by 
reporting and responding urgently when you are exposed 
to blood and/or body fluids. 
If you have any questions about the procedure, please 
call Employee Health Services at 402-8869, page the 
Employee Health nurse on call via the page operator 
(402-8999), or call the Needlestick Hotline at 402-STIK. 
LOVAR Study News 
Pertinent study information, containing 
inclusion and exclusion criteria, is available to 
physicians in a quick reference brochure 
format. 
For your own personal copy, please call the 
LOVAR office at (61 0) 402-4088. 
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Physician Assistance Program 
The Medical Staff of Lehigh Valley Hospital recognizes that 
a wide range of problems in life can affect a physician's 
health and well-being, and, at times, professional 
performance. 
In fact, studies conducted by the National Institute for 
Occupational Health and Safety report that physicians, 
along with other caregivers, may have a higher than 
average risk of developing debilitating personal problems. 
Since 1993, the Physician Assistance Program has been 
available to help members of the Medical Staff deal with 
personal problems before they affect health, family life, or 
professional effectiveness. 
The Physician Assistance Program is a confidential (and if 
so desired, anonymous), professional counseling and 
referral service available to active members of the Medical 
Staff of Lehigh Valley Hospital and their dependents. 
This service is provided through an agreement with 
Preferred EAP which operates the Lehigh Valley Hospital's 
Employee Assistance Program (EAP) and has been 
( involved with over 3,000 employees and dependents since 
1985. 
The Physician Assistance Program offers physicians and 
their families counseling services for a wide range of 
personal-problems - anything that can tum stress into 
distress - including marital or relationship difficulties; 
depression and anxiety; alcohol or drug abuse; family 
problems, or stress from work or personal concerns. 
Program users can choose from a multi-disciplinary team 
assembled to provide Physician Assistance Program 
services. This team includes: 
0 Michael W. Kaufmann, MD, Chairperson, Department 
of Psychiatry 
0 John C. Turoczi, EdD, licensed psychologist and 
member of the Allied Health Professional Staff of 
Lehigh Valley Hospital 
0 Staff of Preferred EAP including licensed social 
workers, masters level clinicians, and certified 
addiction counselors. 
To use the Physician Assistance Program during normal 
working hours, telephone the Preferred EAP office at (610) 
433-8550 or 1-800-327-8878, identify yourself ONLY as a 
member of the Lehigh Valley Hospital's Medical Staff (or a 
family member), and ask to speak to the Program Manager, 
Robin Chase. Please note that callers may remain 
anonymous. 
Ms. Chase, or the Preferred EAP receptionist, will conduct 
a brief telephone interview, offer a choice among the above 
listed provider team members, and advise the caller how to 
arrange an appointment. 
Other professional staff of Preferred EAP are available after 
hours to respond to emergency situations. 
The number of visits will vary with the nature and severity 
of the problem. Up to five visits with Physician Assistance 
Program providers are available to active Medical Staff 
members (and their dependents) at no cost. 
If their is a need for further service or treatment, a referral 
may be made to a private practitioner or community 
resource, or the user may continue with the original 
Physician Assistance Program provider on a self-pay basis. 
For more information, contact Robin Chase at Preferred 
EAP at 433-8550, or John W. Hart, Vice President, in 
Medical Staff Services, at 402-8980, or any member of 
TROIKA. 
A Message from the 
Eastern Pennsylvania 
Funeral Directors Association 
Due to a changing attitude in today's society, 
cremation is becoming more prevalent. Both 
Lehigh and Northampton counties require that 
the coroner's office be provided with a 
completed death certificate before cremation 
can take place. In many cases, when death 
certificates are not procured immediately, 
many families incur added expenses for 
embalming or refrigeration of the deceased. 
In order to avoid these added expenses for 
your patients' families, when at all possible, 
please complete death certificates in an timely 
manner. Your cooperation is truly 
appreciated. 
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Coming Soon to a TV Near You-
The Health Channel 
The Health Channel provides continuing medical 
education {CME) and continuing education {CE) 
programming, as well as other health education to the 
three million healthcare practitioners in the United 
States. 
The Center for Educational Development and Support 
has arranged for Lehigh Valley Hospital to receive a one-
month trial of TiP-TV during the month of April. TiP-TV 
includes The Health Channel (a 24-hour, 7 day per 
week, health education channel), Diagnostic Imaging 
{the original TiP-TV channel for medical imaging 
professionals}, and Focus on Healthcare {covering a 
wide range of compelling healthcare topics). The 
programming will be delivered through the hospital's 
main cable system at Cedar Crest. & 1-78 and 17th & 
Chew on Channel26. 
The Health Channel keeps healthcare professionals 
educated and helps them meet their continuing 
education requirements. Fulfilling continuing education 
requirements ensures optimal patient care and keeps 
healthcare professionals at the forefront of medicine. 
Look to The Health Channel for up-to-date expert 
presentations, informed roundtable discussions, and 
news about medical discoveries, disease management 
and treatments. 
To learn more about The Health Channel, visit their Web 
site at http://www.healthchannelweb.com. 
Renal Enhancement Program 
James E. Kintzel, MD, Director, Peritoneal Dialysis, has 
been the driving force behind the need to provide renal 
educational programs to the Lehigh Valley community. 
One such program available to patients who have been 
newly diagnosed with chronic renal failure is the Renal 
Enhancement Program. 
The Renal Enhancement Program, a two-part program 
offered free of charge to patients and their families, 
provides information regarding treatment options, 
nutrition, lifestyle changes, and ways to cope. 
The next two-part program will be held on May 17 and 
24, from 6 to 8 p.m., in Conference Room 1 B of the Jo~n 
and Dorothy Morgan Cancer Center. Light refreshme( 
will be served. 
For more information, please contact Joan Noll in 
Peritoneal Dialysis at {610) 402-0600. 
News from Nuclear Medicine at 
MHC 
The Nuclear Medicine Department at Muhlenberg 
Hospital Center is pleased to announce an exciting new 
imaging method for detecting acute deep venous 
thrombosis (DVT). 
Acutect (Technetium-99m labeled Apcitide) is a unique, 
synthetic peptide radiopharmaceutical indicated for 
scintigraphic imaging of acute venous thrombosis in the 
lower extremities. This is the first imaging modality to 
target acute DVT. Imaging of the lower extremities is 
performed both 10 minutes and 60 minutes following 
intravenous injection of the radiopharmaceutical. 
( 
While this technique does not replace ultrasound or 
venography, it may be helpful in those patients who have 
indeterminate or equivocal sonographic findings, are 
technically difficult to scan (e.g., large body habitus), 
have an overlying cast, or in those cases where 
determining acute {vs. chronic) DVT is of clinical 
importance. 
If you have any questions regarding this issue or have 
patients who would benefit from this study, please 
contact Gregg D. Schubach, MD, Director of Nuclear 
Medicine (MHC), or Dave Steigerwalt, Nuclear Medicine 
supervisor, at (610) 861-2232. 
Daylight Savings 
Sunday, Apri/4 
Don't forget to turn 
your clocks ahe~rtl 
\ 
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MHC Phamis Implementation 
( Update 
( 
At the end of April, Phamis Lastword will be implemented 
at Muhlenberg Hospital Center. It will replace the 
existing Hospital Information System which is not year 
2000 compliant. 
Patient related information available on-line regardless of 
the facility where the visit occurred includes: 
• Demographics 
• Lab results 
• Ancillary results (such as Radiology reports) 
• Transcriptions (H&Ps, Operative Notes, Discharge 
Summaries, etc.) 
• Allergy and Intolerance information 
• Orders 
• Medications and IVs 
To introduce and prepare physicians for this new system, 
education sessions have been scheduled as follows: 
• Monday, April26- 5:45 to 7:15p.m. 
• Tuesday, April27- 7 to 8:30a.m. 
• Tuesday, April 27- Noon to 1:30 p.m. 
• Wednesday, April 28 - 7 to 8:30 a.m. 
• Wednesday, April 28 - Noon to 1 :30 p.m. 
• Thursday, April29- 5:45 to 7:15p.m. 
All classes will be held in the First Floor Computer 
Training Room at Muhlenberg Hospital Center. 
Registration for class is requested. To register, please 
contact Diane Zapach in Physician Relations at (61 0) 
402-9192. 
Affinity's Diabetic Foot and Wou~d 
Care Program Receives Generous 
Donation 
Affinity's Diabetic Foot and Wound Care Program, 
directed by Larry N. Merkle, MD, Chief, Division of 
Endocrinology/Metabolism, was recently honored to 
receive a generous donation from an anonymous donor. 
The donor and her husband were successfully treated at 
Affinity's wound care program a few years ago, and in 
fact, provided their first donation to the program at that 
time. The first donation allowed Affinity to purchase a 
Gait Analysis System which has been instrumental in the 
treatment and prevention of foot ulcers. The most recent 
donation will be used in many ways to further enhance 
the five year old program, including: a computer/data 
collection system for measurement of outcomes, a 
Tekscan F-socket to enhance care for blk amputees via 
the computerized gait analysis system, an indigent care 
fund for those without insurance, and some equipment 
upgrades. 
The Diabetic Foot and Wound Care Program provides a 
multi-disciplinary team approach to wound care. This 
team includes endocrinologists, podiatrists, pedorthists, 
orthatists, nurse patient educators, and various physical 
therapists and physical therapy assistants. The success 
of this program and the wonderful treatment the patients 
receive is a direct result of the expertise of Affinity's 
team. 
Affinity's Diabetic Foot and Wound Care Clinic is held on 
Mondays from 2 to 5 p.m. at Affinity, 1243 S. Cedar 
Crest Blvd., First Floor. For more information, please call 
Affinity at 402-9292. 
Congratulations/ 
James T. McNelis, DO, Division of General Internal 
Medicine/Geriatrics, was recently elected a Fellow of the 
American College of Physicians. 
Craig J. Sobolewski, MD, Division of Primary Obstetrics 
and Gynecology, was recently notified that he has 
fulfilled all necessary requirements and is now a certified 
Diplomate of the American Board of Obstetrics and 
Gynecology. 
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Papers, Publications and 
Presentations 
George A. Arangio, MD, Associate Chief, Division of 
Orthopedic Surgery {LVH}, co-authored the paper, 
"Mathematical modeling of support distribution under the 
foot,· which was published in Journal of the 
Pennsylvania Academy of Science. 
Scott Beman, MD, general surgery resident, presented 
a poster on "Higher cyclosporine levels decrease kidney 
rejection episodes without increasing nephrotoxicity" at 
the Eastern Pennsylvania Chapter of the American 
College of Surgeons meeting. Co-authors include Craig 
R. Reckard, MD, Chief, Section of Transplantation 
Surgery; Douglas E. Johnson, MD, Division of 
Nephrology; and Thomas E. Wasser, PhD, Director of 
Health Studies. 
K. Lesley Birmingham, MD, Chief Resident in Plastic 
Surgery, presented her paper on "Patterns of pediatric 
facial trauma in motor vehicle collisions" at the Joint 
Scientific Meeting on Plastic Surgery in London. Co-
authors include Robert X. Murphy, Jr., MD, and Walter 
J. Okunski, MD, of the Division of Plastic and 
Reconstructive Surgery; and Thomas E. Wasser, PhD. 
Dr. Birmingham presented the paper as a poster at the 
Pennsylvania Committee on Trauma Residents' Trauma 
Paper Competition. 
Mehrzad Bozorgnia, MD, general surgery resident, 
presented his paper, "lnfrainguinal bypass in patients 
with end-stage renal disease: Survival and ambulation," 
at the Surgical Forum of the American College of 
Surgeons Fall meeting. Co-authors of the paper include 
Gary G. Nicholas, MD, Chief, Division of Vascular 
Surgery and Program Director of the General Surgery 
Residency, Susan A. Nastasee, Surgical Editor, and 
James F. Reed Ill, PhD, Department of Community 
Health. Dr. Bozorgnia also presented a poster of the 
paper at the Eastern Pennsylvania Chapter of the 
American College of Surgeons meeting. 
Mark D. Cipolla, MD, PhD, Chief, Section ofTrauma 
Research and Associate Chief, Division of Trauma-
Surgical Critical Care, presented the poster, "Soluble 
endothelial cell adhesion molecules in patients with 
septic shock," at the Association for Academic Surgery. 
Co-authors include Kathy Gottlund, Biological Therapy 
Lab, Leslie Saga, Trauma Program Development, and 
Michael D. Pasquale, MD, Chief, Division of Trauma-
Surgical Critical Care. Dr. Cipolle also presented a . 
poster on "Long-term follow-up in trauma patients wit~ 
vena cava filter" at the American Association for the 
Surgery of Trauma. His co-authors include Ivy Fearen, 
Trauma Program Development, and Dr. Pasquale. 
E. James Frick, Jr., MD, Chief Surgical Resident; Linda 
L. Lapos, MD, Division of Colon and Rectal Surgery; 
and H. David Vargas, MD, former member of the 
Division of Colon and Rectal Surgery, co-authored the 
paper, "Solitary neurofibroma of the anal canal, • which 
will be published in Diseases of the Colon & Rectum. 
In addition, Dr. Frick, along with Michael D. Pasquale, 
MD, and Mark D. Cipolle, MD, PhD, co-authored the 
paper, "Small bowel and mesentery injuries in blunt 
trauma," which was accepted for publication in the 
Journal of Trauma. Dr. Frick presented the paper as a 
poster at the annual meeting of the Society of Critical 
Care Medicine. 
Dr. Frick also presented "Somatostatinoma of the 
ampulla of Vater in celiac sprue" as a poster at the 1999 
Americas Hepato-Pancreato-Biliary Congress. Herbert 
C. Hoover, Jr., MD, Chairperson, Department of ( 
Surgery, was co-author. ·. 
Patrick Gonzalez, Jr., MD, resident in surgical critical 
care, presented his paper, "Reduction of catheter-
associated central line sepsis in a bum unit: A new 
method of catheter care," at the Eastern Pennsylvania 
Chapter of the American College of Surgeons meeting 
and the Pennsylvania Committee on Trauma Residents' 
Trauma Paper Competition. Co-authors include Minh Ly 
T. Nguyen, MD, Division of Infectious Diseases, 
Bernadette Kratzer, RN, and Terry Burger, RN, 
Infection Control Department, Elaine Walz, RN, Cancer 
Program, and Kevin J. Farrell, MD, Chief, Section of 
Bum. Dr. Gonzalez also presented the paper as a 
poster at the meeting of the Society of Critical Care 
Medicine. 
In addition, Dr. Gonzalez presented a poster on "Violent 
firearm injuries: A pleas for prevention" at the 
Pennsylvania Committee on Trauma Residents' Trauma 
Paper Competition. Co-authors include Michael D. 
Pasquale, MD, Mark D. Cipolle, MD, PhD, and Judith 
M. Schultz, Trauma Development. ( 
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Tito Gorski, MD, former colon and rectal surgery 
resident; Lester Rosen, MD, Associate Chief, Division of 
Colon and Rectal Surgery; Robert D. Riether, MD, 
Director, Colon and Rectal Residency Program; John J. 
Stasik, MD, Chief, Division of Colon and Rectal Surgery, 
and lndru T. Khubchandani, MD, Division of Colon and 
Rectal Surgery, co-authored the paper, "Colorectal 
cancer after surveillance colonoscopy: False negative 
exam or fast growth?", which will be published in 
Diseases of the Colon & Rectum. 
In addition, Dr. Gorski and Dr. Rosen, along with Susan 
Lawrence and Douglas Helfrich of the Department of 
Care Management Systems, and James F. Reed Ill, 
PhD, Department of Community Health, co-authored the 
paper, "Usefulness of a state-legislated, comparative 
database to evaluate quality in colorectal surgery,• which 
will be published in Diseases of the Colon & Rectum. 
Dr. Gorski and Dr. Khubchandani also co-authored the 
paper, "Retrorectal carcinoid tumor,• which will be 
published in Southern Medical Journal. 
"Adverse Effects of Outpatient Parenteral Antibiotic 
Therapy,• an article authored by Margaret L. Hoffman-
Terry, MD, Division of Infectious Diseases, was 
published in the January 1999 issue of the American 
Journal of Medicine. 
Herbert C. Hoover, Jr., MD, Chairperson, Department 
of Surgery, co-authored the paper 
"Radioimmunoscintigraphy of recurrent, metastatic, or 
occult colorectal cancer with technetium Tc 99m 
88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally 
human monoclonal antibody,• which was published in 
Diseases of the Colon & Rectum. 
Peter A. Keblish, Jr., MD, Chief, Division of Orthopedic 
Surgery, was the moderator of a two-day Advanced 
Learning Center on Mobile Bearing Total Knee 
Arthroplasty, which was held in conjunction with the 
American Academy of Orthopaedic Surgeons meeting 
held in Anaheim, Calif. Dr. Keblish also presented 
several papers on topics of primary and revision total 
knee arthroplasty. 
!n addition, Dr. Keblish authored an article, "The Artificial 
Hip," which was published is Doctors Forum. The 
article is directed primarily at the general public to 
enhance their understanding of total hip replacement. 
Michael T. Kennedy, MD, and Randolph Wojcik, MD, 
general surgery residents; Mark D. Cipolle, MD, PhD, 
James G. Cushman, MD, Chief, Section of Pediatric 
Trauma, and Michael D. Pasquale, MD, co-authored the 
paper, "Incorporation of focused assessment for the 
sonographic examination of the trauma patient (FAST) 
into an algorithm for evaluation of blunt abdominal 
trauma: A prospective study," which was presented at 
several regional and national meetings, including a 
poster presentation at the Society of Critical Care 
Medicine, and an oral presentation at the Eastern 
Pennsylvania Chapter of the American College of 
Surgeons meeting. Dr. Kennedy won an educational 
scholarship award for his presentation at the Society of 
Critical Care Medicine. In addition, Dr. Kennedy 
presented the paper at the Pennsylvania Committee on 
Trauma Residents' Trauma Paper competition and the 
Region Ill American College of Surgeons Committee on 
Trauma Residents' Trauma Paper Competition where he 
won first place for both presentations. 
Daniel M. Morrison, MD, surgical resident; Michael D. 
Pasquale MD, Chief, Division of Trauma-Surgical Critical 
Care; and Charles J. Scagliotti, MD, Division of 
General Surgery/Trauma-Surgical Critical Care, co-
authored the paper, "Hydrostatic rectal injury of a jet ski 
passenger: Case report and discussion,· which was 
published in the Journal of Trauma. 
W. Michael Morrissey, Jr., DMD, MD, plastic surgery 
resident, presented his paper, "The increase in TRAM 
flap survival after delay does not diminish long-term," at 
the Eastern Pennsylvania Chapter of the American 
College of Surgeons meeting. Geoffrey G. Hallock, 
MD, Associate Chief, Division of Plastic and 
Reconstructive Surgery (LVH), was co-author. 
Michael D. Pasquale, MD, Chief, Division of Trauma-
Surgical Critical Care, presented his paper, "Decreased 
resource utilization, length of stay, and costs using a 
trauma operations improvement team,· at the Society of 
Critical Care Medicine meeting. Co-authors include 
James G. Cushman, MD, and Kevin E. Glancy, MD, 
Division of Trauma-Surgical Critical Care/General 
Surgery; Mary Jean Osborne, Director, Open Heart Unit 
and Transitional Open Heart Unit; Juliet Fischer, 
Trauma Coordinator; Betsy Seislove, Patient Care 
Specialist; and Judith M. Schultz, Trauma 
Development. Dr. Pasquale also presented a poster, 
"Should routine helmet use be required for recreational 
skiers?" at the Society of Critical Care Medicine meeting. 
(Continued on Page 10) 
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In addition, Dr. Pasquale presented his paper, "Outcome 
analysis of Levell and Level II trauma centers," at the 
American Association for the Surgery of Trauma. Co-
authors include Andrew Peitzman, MD, of the University 
of Pittsburgh, and Thomas E. Wasser, PhD, Director of 
Health Studies. The paper has been submitted to the 
Journal of Trauma. 
Rovinder "Bob" Sandhu, MD, general surgery resident, 
presented a poster on "Measurt::ment of endotracheal 
tube cuff leak to predict post-extubation stridor and need 
for reintubation" at the Eastern Pennsylvania Chapter of 
the American College of Surgeons meeting and the 
meeting of the Society of Critical Care Medicine. Co-
authors include Michael D. Pasquale, MD, Kenneth 
Miller, Respiratory Therapist, and Thomas E. Wasser, 
PhD. 
Upcoming Seminars, 
Conferences and Meetings 
Emergency Medicine Grand Rounds 
Grand Rounds, sponsored by the Department of 
Emergency Medicine, will be held on Thursday, April1, 
from 9 a.m. to 1 p.m., in the Emergency Medicine 
Institute, 1251 S. Cedar Crest Blvd., Suite 308C. 
Topics to be discussed include: 
• Carbon Monoxide and Cyanide Poisoning - Gary 
Bonfante, DO 
• Pediatric Abdominal Pain - Ronald A. Lutz, Sr., MD 
For more information, please contact Judy Szep in the 
Department of Emergency Medicine at 402-7168. 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday 
beginning at noon in Lehigh Valley Hospital's Auditorium 
at Cedar Crest & 1-78. 
Topics to be discussed in April include: 
• AprilS- Ventricular Tachycardia- What's New? 
• April13 - Update on Staphylococcal Disease 
• April 20 - Benefits & Toxicity of Non-Steroidals with • 
an Evaluation of the Safety of the new COX II (c 
Inhibitors 
• April27- Medical Ethics are Unethical Public Policy 
For more information, please contact Evalene Patten in 
the Department of Medicine at 402-1649. 
Department of Pediatrics 
The Department of Pediatrics conferences are held on 
Fridays beginning at noon in Lehigh Valley Hospital's 
Auditorium at 17th & Chew. 
Topics to be discussed in April include: 
• April 23 - Syncope in Adolescents 
For more information, please contact Kelli Ripperger in 
the Department of Pediatrics at 402-2540. 
"Respiratory and Neurological Challenges for 
Today's Children: From Hospital to Home," a two-
day conference sponsored by the Department of 
Pediatrics, will be held April7 and 8, from 8 a.m. to 4{" 
p.m. both days, in the Lehigh Valley Hospital Auditori~ •.. 
at Cedar Crest & 1-78. 
The conference is designed for physicians, nurses, nurse 
practitioners, and other healthcare providers who 
participate in the planning, implementation, evaluation, 
and revision of patient care for children with acute and 
chronic respiratory and/or neurological illness. 
For more information, please contact Kelly Beauchamps 
in the Center for Education at 402-1700. 
Stahler-Rex Health Care Lecture 
Richard Lamm, former Governor of Colorado, will be the 
featured speaker at this year's Stahler-Rex Health Care 
Lecture scheduled for Tuesday, April 27, beginning at 7 
a.m., in the Auditorium at Lehigh Valley Hospital, Cedar 






Medical Staff Progress Notes April, 1999 • Volome 11, Number 4 Pagell 
Who's New 
The Who's New section of Medical Staff Progress Notes 
contains an update of new appointments, address 
changes, status changes, etc. Please remember to update 
your directory and rolodexes with this information. 
Medical Staff 
Appointments 
Andrea B. Gonzalez-Torrado, MD 
Children's HealthCare 
Children's HealthCare Center 
1517 Pond Road 
Allentown, PA 18104-2250 
(61 0) 395-4444 
Fax: (610) 366-7886 
Department of Pediatrics 
Division of General Pediatrics 
Site of Privileges - LVH & MHC 
Provisional Active 
Richard F. Goy, MD 
L VPG-Medicine 
Trexlertown Convenience Center 
6900 Hamilton Blvd. 
P.O. Box60 
Trexlertown, PA 18087-0127 
Department of Medicine 
Division of General Internal Medicine 
Site of Privileges - LVH & MHC 
Provisional Active 
Gregor M. Hawk, MD 
Orthopedic Associates of Allentown 
1243 S. Cedar Crest Blvd., Suite 2500 
Allentown, PA 18103-7982 
(610) 433-6045 
Fax: (610) 433-3605 
Department of Surgery 
Division of Orthopedic Surgery 
Site of Privileges - LVH & MHC 
Provisional Active 
Larry Levin, MD 
Muhlenberg Primary Care, PC 
2597 Schoenersville Road 
Suite 302 
Bethlehem, PA 18017-7309 
(610) 868-6880 
Fax: (610) 868-5333 
Department of Medicine 
Thong P. Le, MD 
(Solo Practice) 
Pasteur Merieux Connaught 
Route 611, P.O. Box 187 
Swiftwater, PA 18370 
(717) 839-6144 
Fax: (717) 839-0934 
Department of Medicine 
Division of Infectious Diseases 
Site of Privileges: MHC 
Provisional Associate 
Division of General Internal Medicine 
Site of Privileges - LVH & MHC 
Provisional Active 
Medical Staff Proress Notes 
Glenn A. Mackin, MD 
Lehigh Neurology 
1210 S. Cedar Crest Blvd. 
Suite 1800 
Allentown, PA 18103-6208 
(610) 402-8420 
Fax: (610) 402-1689 
Department of Medicine 
Division of Neurology 
Site of Privileges· LVH & MHC 
Provisional Active 
Sarah L Stevens, MD 
LVPG-Medicine 
Lehigh Valley Family Health Center 
1730 Chew Street 
Allentown, PA 18104-5595 
(610) 402-3500 
Fax: (610) 402-3509 
Department of Medicine 
Division of General Internal Medicine 
Site of Privileges • LVH & MHC 
Provisional Active 
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Deborah L Villeneuve, MD 
Lehigh Valley Women's Health Care Alliance 
1575 Pond Road, Suite 1 04 
Allentown, PA 18104-2250 
(610) 398-7848 
Fax: (610)398-2220 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
Site of Privileges • L VH & MHC 
Provisional Active 
Practice Changes 
Martin LeBoutillier Ill, MD 
( 
(No longer with Panebianco-Yip Heart Surgeons) ( 
The Heart Care Group, PC 
1210 S. Cedar Crest Blvd., Suite 2300 
Allentown, PA 18103-6286 
(610) 437-5505 
Fax: (61 0) 437-5763 
William J. Liaw, DO 
(No longer with Primary Care Associates in the LV, PC) 
Macungie Medical Group 
3261 Route 100 
P.O. Box487 
Macungie, PA 18062-9389 
(61 0) 966-4646 
Fax: (610) 965-6201 
Theodore G. Phillips, MD 
(No longer with Panebianco-Yip Heart Surgeons) 
The Heart Care Group, PC 
1210 S. Cedar Crest Blvd., Suite 2300 
Allentown, PA 18103-6286 
(610) 437-5505 
Fax: (610) 437-5763 
Michael C. Sinclair, MD 
(No longer with Panebianco-Yip Heart Surgeons) 
The Heart Care Group, PC 
1210 S. Cedar Crest Blvd., Suite 2300 { 
Allentown, PA 18103-6286 
(610) 437-5505 
Fax: (610) 437-5763 
Medical Staff Progress .Notes 
Raymond L. Singer, MD 
(No longer with Panebianco-Yip Heart Surgeons) 
( The Heart Care Group, PC 
1210 S. Cedar Crest Blvd., Suite 2300 
Allentown, PA 18103-6286 
(610) 437-5505 
Fax: (610) 437-5763 
Address Changes 
John B. Paulus, DO 
Allentown Internal Medicine, Ltd. 
2895 Hamilton Blvd., Suite 101 
Allentown, PA 18104-6192 
(61 0) 776-6666 
Fax: (610) 776-0179 
Albert J. Peters, DO 
Allentown MedicaJ.Center 
401 N. 17th Street, Suite 312 
Allentown, PA 18104-5104 
(61 0) 402-9522 
Fax: (610) 402-9649 
New Fax Number 
Primary Care-Associates in the LV, PC 
( -Shawn R. Ruth, DO 
- David M. Stein, DO 
New Fax: (610) 776-6344 
Status Changes 
Frank J. Altomare, Jr., MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Nuclear Medicine 
From Active to Emeritus Active 
Matthew A. Kasprenski, Sr., MD 
Department of Family Practice 
From Affiliate to Emeritus Affiliate 
E. Brian Petrasek, MD 
Department of Family Practice 
From Provisional Active to Provisional Affiliate 
John F. Pifer, DO 
Department of Family Practice 
From Affiliate to Emeritus Affiliate 
Christopher Stella, MD 
From: Department of Medicine 
Section: House 
( Category: Active 
To: Department of Emergency Medicine 
Division of Emergency Medicine 
Category: Limited Duty 
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Resignation 
William E. Tucker, MD 
Department of Emergency Medicine 
Division of Emergency Medicine 
Provisional Active 
Allied Health Professionals 
Appointments 
Dena L. Capobianco, PA 
Physician Extender 
Physician Assistant- PA 
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(Gastroenterology Associates Ltd. - Michael H. Ufberg, MD) 
Alice Gallagher, CRNP 
Physician Extender 
Professional - CRNP 
(John J. Cassel, MD, PC -John J. Cassel, MD) 
Karen A. Moffat, RN 
Physician Extender 
Professional- RN 
(Yeisley Cardiothoracic Surgery, LLC- Geary L. Yeisley, MD) 
Anthony J. Pack, PA·C 
Physician Extender 
Physician Assistant- PA-C 
(The Heart Care Group, PC - Theodore G. Phillips, MD) 
Donna F. Petrucelli, CRNP 
Physician Extender 
Professional- CRNP 
(The Heart Care Group, PC - James A. Sandberg, MD) 
Doris M. Vasko 
Physician Extender 
Technical- Medical Assistant 
(ABC Family Pediatricians • Donald L. Levick, MD) 
Changes of Supervising Physician 
David A. Cederberg 
Physician Extender 
Technical- Surgical Technician 
From: Antonio C. Panebianco, MD- Panebianco-Yip Heart 
Surgeons and Geary L. Yeisley, MD- Yeisley Cardiothoracic 
Surgery, LLC 
To: Geary L. Yeisley, MD- Yeisley Cardiothoracic Surgery, LLC 
Lee E. Speed, PA·C 
Physician Extender 
Physician Assistant- PA-C 
From: Theodore G. Phillips, MD 
To: Michael C. Sinclair, MD- The Heart Care Group, PC 
George M. Walton, PA.C 
Physician Extender 
Physician Assistant - PA-C 
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From: Antonio C. Panebianco, MD- Panebianco-Yip Heart 
SUrgeons 
To: Michael C. Sinclair, MD- The Heart Care Group, PC 
Resignations 
Barbara M. Enger, RN 
Physician Extender 
Professional - RN 
(David L Schwendeman, MD) 
Claudette M. Geist 
Physician Extender 
Technical- SUrgical Technician 










THERAPEUTICS AT A GLANCE 
The followina actions were taken at the January/February 1999 Therapeutics Committee Meeting - Rebecca Hockman, 
Pharm.D., BCPS, Christopher Moore, R.Ph., Joseph Ottinger, R.Ph., MS, MBA 
ENOXPARIN FOR 
UNSTABLE ANGINA 
Two recent trials (ESSENCE AND TIM! 
llb) involving enoxaparin and aspirin vs 
UFH (unfractionated heparin)· and aspirin 
in the treatment of unstable angina were 
presented at the February Therapeutics 
Committee meeting. Both studies 
appeared to support the use of the LMWH 
(low molecular weight heparin) product 
arm. Their was a statistically significant 
relative risk reduction (RRR) in the 
respective triple end points of both studies 
(death, MI, and recurrent angina in 
ESSENCE; death, Ml, and the need for 
urgent revascularization in TIMI 11 b) in 
comparison with the UFH arm. 
However, there was some concern about 
aspects of the two studies and their 
analysis that should be noted. The 
importance of adequate anticoagulation has 
been recognized in studies of agents touted 
as replacements for UFH. The use of 
empirical dosing of IV UFH has been 
shown to produce inadequate levels of 
anticoagulation. The empirical dosing 
protocol used in the ESSENCE trials 
resulted in less than half of the patients 
treated with UFH achieving an aPTT in 
the target range by 24 hours. Certainly 
this may have biased the results in favor of 
enoxaparin. Secondly, the importance of 
achieving a single targeted aPTT has been 
frequently questioned. This may be 
related to the need for each institution with 
different equipment, personnel and 
thromboplastin reagents for aPTT tests to 
establish its own UFH sensitivity curve. 
The guidelines of the American College of 
Chest Physicians currently recommend that 
the goal for UFH therapy should 
correspond to a blood concentration of 
0.2-0.4 units/mi. Therefore, as with 
warfarin monitoring prior to use of the 
INR, therapeutic heparin monitoring via 
the use of aPTT can be deceiving. Both 
the ESSENCE and TIM! llb trials utilized 
multiple institutions (176 and 200, 
respectively) and were carried out in 10 
countries. One must at least consider that 
so many disparate institutions did not have 
identical sensitivity curves which could 
have affected the observed outcomes. 
Finally, although the triple end points were 
statistically significant, the individual end 
. points of death, MI and revascularizationl 
recurrent angina did not achieve statistical 
significance in the ESSENCE trial. The 
highest positively correlated data involved 
recurrent angina. Death and MI trended 
toward the LMWH treatment arm, but 
were not statistically significant. Recently, 
the Fifth ACCP Consensus Conference on 
Antithrombotic Therapy gave the use of 
LMWH for unstable angina an A2 
recommendation (Methods strong, results 
consistent, effect equivocal-uncertainty 
whether benefits outweigh the risks). 
Currently, a bag of unfractionated heparin 
costs $2.85 each, while an aPTT test costs 
@$3.50 each. The ctaily drug acquisition 
cost for enoxaparin in a 70 kg individual 
would be $62.00 at the recommended dose 
of lmg/kg every 12 hoilrs. The average 
treatment duration was a little less than 3 
days in the ESSENCE trial with a range of 
2-8 days. Treatment with aspirin was 
continued in all the studies after the 
LMWH was stopped. 
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EMESIS NEMESIS 
Dolasetron injectable (Anzemet) is 
indicated for the prevention and treatment 
of postoperative nausea and vomiting. At 
higher doses this agent can also be utilized 
to prevent nausea and vomiting associated 
with initial and repeated courses of 
moderately emetogenic chemotherapy. 
However, a review of this indicated use 
was not pursued at this time. 
Dolasetron is a potent, selective and 
reversible 5-HT3 receptor antagonist. Its 
clinical activity appears to be due to its 
reduced metabolite, hydrodolasetron, 
which is 50 to 100 times more potent than 
dolasetron. 
For the prevention of postoperative nausea 
and vomiting, the recommended adult 
intravenous dose is 12.5 mg given as a 
single dose approximately 15 minutes 
before the cessation of anesthesia. The 
same dose may be administered for the 
treatment of post-operative nausea and 
vomiting, administered as soon as nausea 
or vomiting occurs. In pediatric patients, 
2 to 16 years of age, the recommended 
intravenous dose is 0.35 mg/kg, up to a 
maximum dose of 12.5 mg, given as a 
single dose approximately 15 minutes 
before the cessation of anesthesia or as 
soon as nausea or von;:riting occurs. 
CONCLUSION: Dolasetron offers an 
alternative to ondansetron (Zofran) and 
granisetron (Kytril) in the prevention of 
nausea and vomiting, although no 
advantages over these agents have been 
demonstrated. Dolasetron appears as 
effective as these agents, with a similar 
side effect profile. The ECG changes 
noted with dolasetron are a class effect ' 
but appear to be more pronounced with 
dolasetron. These effects are generally 
seen at higher doses and the overall 
clinical implications are unclear. The 
perceived equivalent doses of ondansetron 
and dolasetron are 4mg and 12.5mg, 
respectively for PONV. Currently, the 
cost difference for the aforementioned 
doses of ondansetron ($ 17 .1 0) and 
do~asetron ($ 10.20) is fairly substantial. 
Cost is likely to continue to be a major 
factor in the selection of a 5-HT3 receptor 
antagonist for formulary inclusion as all 
three available agents appear to be 
effective at "equivalent doses" . The 
Anesthesia subcommittee has trialed 
dolasetron in selected patients using a 
12.5mg dose given about 15 minutes prior 
to the end of the procedure. This dose 
and agent have been included in the adult 
Post-Operative Antiemetic 
Prophylaxis/Treatment algorithm. 
Therefore, the recommendation was to 
approve this agent to the Formulary for 
use in the adult PONV algorithm or as a 
single 12.5 mg "rescue" dose . Use of 
this agent in the prevention and treatment 
of chemotherapy induced nausea and 
vomiting will be reviewed at a future time. 
ANOTHER 'CAINE' ADDED 
TO THE FORMULARY 
Ropivacaine (N aropin) is indicated for 
production of local anesthesia or regional 
anesthesia for surgery, postoperative pain 
management and obstetrical procedures. 
In surgical anesthesia, it is indicated for 
epidural block for surgery including 
cesarean section, major nerve block and 
local infiltration. In acute pain 
management, it is indicated for use as an 
epidural continuous infusion or intermittent 
bolus (e.g., postoperative pain or labor) 
and local infiltration. 
Ropivacaine is an amide-type local 
anesthetic and an analog of bupivacaine 








in water-soluble form as the hydrochloride 
monohydrate salt. Ropivacaine is less 
lipid-soluble than bupivacaine. Unlike 
bupivacaine and mepivacaine which are 
available as racemates, ropivacaine is 
available only as the S-isomer. It appears 
that the S-isomers of these local 
anesthetics are responsible for greater 
anesthetic activity, while the R-isomers are 
responsible for greater toxicity. By 
providing ropivacaine as only the S-
isomer, it is thought that it will provide 
greater local anesthetic potency and less 
local anesthetic toxicity than the racemic 
mixture. 
Table 1: Structural classification of local 
anesthetics: 










Ropivacaine has been less toxic than 
bupivacaine in animal studies. The ratio 
between lethal and convulsive doses is 
higher with ropivacaine than with 
bupivacaine, and ropivacaine is less potent 
than bupivacaine at inducing cardiac 
arrhythmias. After intravenous 
administration to volunteers, ropivacaine 
produced less central nervous system and 
cardiovascular toxicity than bupivacaine. 
Although less toxic than bupivacaine, 
ropivacaine is more toxic than lidocaine. 
Epidural administration of 0.5%, 0. 75% 
and 1 % ropivacaine. produced similar 
durations of sensory and motor blockade in 
one study, while in another study epidural 
ropivacaine 0. 75% and 1% demonstrated a 
longer duration of analgesia and more 
~pid onset of motor blockade than the 
0.5% concentration. All three doses 
produced effective sensory blockade, and 
maximal muscle weakness occurred 1 to 
1. 5 hours after administration; however, at 
the higher dose the intensity and duration 
of motor blockade increased. The duration 
of analgesia for 0.5% ropivacaine has been 
estimated to be between those of 2% 
mepivacaine with epinephrine and 0.5% 
bupivacaine with epinephrine, while the 
duration of analgesia for 0. 7 5% 
ropivacaine is comparable to that of 0.5% 
b~pivacaine with epinephrine. 
CONCLUSION: Ropivacaine appears to 
be an effective local anesthetic with 
efficacy comparable to bupivacaine. At 
equivalent doses, ropivacaine appears to 
produce comparable analgesia with less 
motor block than bupivacaine. This can 
be advantageous in labor analgesia and 
postoperative analgesia where a loss of 
motor function is not desired. It has been 
suggested that it may provide a safer side 
effect profile than bupivicaine, especially 
related to cardiotoxic effects. However, 
additional large comparative studies are 
needed to determine whether the difference 
is significant. Currently, the cost of an 
equimilligram dose of ropivacaine is twice 
that of bupivacaine. The Chiefs of 
Anesthesia at the MHC, 17th St. and CC 
sites are expected to utilize this agent in 
selected scenarios. 
ADULT PONY GUIDELINES 
APPROVED 
·~ i· 
T!t~. Anesthesia sub-committee put the 
finishing touches on an Adult Post-
Operative Antiemetic Prophylaxis/ 
Treatment algorithm. The fmal version is 
attached. 
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ADULT POST -OPERATIVE ANTIEMETIC PROPHYLAXIS/TREATMENT GUIDELINES 
Recommendations to minimize risk factors for Post Operative Nausea & Vomiting (PONV)* 
-Consider anxlolytics 
Yes No 
-Limit opioids, no nitrous oxide 
-Minimize mask ventilation or pharyngeal stimulation 
-Adequate pain control 
-Adequate hydration 
(1) High Risk Procedure 
A.. Gynecological: Laproscopic, D&C/E 
B. Eye (Except cataracts under MAC) 
C. ENT: T&A, UPPP, Middle ear surgery 
D. Mastectomy (Reconstruction) 
E. Total Knee Replacement 
F. General Surgery; Laparoscopic procedures 







Ondanselron 4mg IV X 1 
<-/- Proctilorperazlne 1·2 
mg IVnM X 1 based on 
patient specific needs. 
Yes 
Droperidol 0.625mg <-
Dolasetron 12.5 mg IV 
15 min prior to end of 
procedure .. <-/-






(2) High Risk Patients: 
No Treatment. ObseJVe 




30-min prior to end of procedure 
+/-
Oolasalron 12.5 mg IV 15 
minutes prior to end of 
proceilure-. 
A. History of prolonged Post-Op nausea and vomiting > 1 episode. 





C. Obesity defined as >30% ideal body weight and premenopausal female. 
D. Failed response to previous antiemetic therapy. 
**if patient meets category 20 above, administer dolasetron 12.5 mg IV X 1 in 
addition to droperidol. 




REMINDERS FOR PRE-OP 
VANCOMYCIN 
L VH healthcare professionals continuously 
work together to limit the spread of 
vancomycin resistant enterococci (VRE). 
Assisting with the appropriate use of 
vancomycin is one method by which the 
occurrence of VRE may be limited. 
Communication with healthcare ·workers, 
and review of miscellaneous patients charts 
reveal several issues in need of 
clarification with respect to L VH pre-op 
vancomycin use. Please fmd these issues 
and suggestions/clarifications for helping 
to solve the issues listed below. 
- Alterations in infusion durations - In 
order to allow for adequate infusion time, 
vancomycin infusions must be initiated on 
the floor prior to sending the patient to the 
OR. This recommendation is part of the 
L VH policy for the administration of 
surgical antibiotic prophylaxis. 
- Documentation - It is extremely important 
to document drug allergies and reaction 
symptoms in the patients history and on .all 
order sheets. Please remember to question 
patients about the allergic symptoms that 
they experience when given the drug to 
which they have allergies. If available, 
this information may be used to limit the 
number of instances where vancomycin is 
the drug therapy selection. It is very 
important that this information be 
transferred to all order sheets, in addition 
to placement in the patient history. 
- Hypersensitivity definition on pre-op 
order sheets. Rationale and clariflcation -
Many pre-op orders at L VH have cefazolin 
as the surgical antibiotic of choice. 
Patients may have a variety of allergic 
symptoms to penicillins, and these may be 
potentially cross-reactive to 
G~phalosporins. Additionally, many 
patients may have allergies to penicillins, 
but tolerate cephalosporins without 
reaction. The hypersensitivity definition 
on the L VH pre-op order sheets is there to 
assist in identifying patients that are the 
most appropriate candidates for pre-op 
vancomycin use. The CDC discourages 
the use of pre-op vancomycin for 
" ... Routine surgical prophylaxis other than 
in a patient who has a life-threatening 
reaction to beta-lactam antibiotics." (MMWR. 
1994;44,RR-12:4.). LVH pre-op order sheets 
suggest that vancomycin use be limited to 
patients that meet the following definitions: 
a) 
b) 
"If allergic to Penicillin/ Cephalosporin 
described as hives and/or respiratory distress 
and/or collapse within minutes of a dosage 
of penicillin or cephalosporin." 
Patients with unobtainable histories for drug 
allergies or reactions 
Thank you for reviewing these issues and 
suggestions for practice improvement. 
Thank you for continuing to work together 
to .c!imit the spread of VRE. Please call 
the-pharmacy at x8884 or x8886 for 




DRUG THERAPY OPTIONS 
ATLVH 
The Therapeutics Committee approved the 
formulary addition of two agents for the 
management of Heparin Induced 
Thrombocytopenia (HIT), to prevent 
further thromboembolic complications 
(TEC)- Danaparoid (Orgaran ®, 
manufactured by Organon), and Lepirudin 
( Refludan ®, r DNA, manufactured by 
Hoechst Marion Roussel). Currently, the 
L VH Therapeutics Committee is restricting 
these agents to use only by Hematology/ 
Page 1 
Oncology physicians. Future alterations to 
this restriction will be reported in 
subsequent newsletters. This report 
provides brief drug reviews for danaparoid 
and lepirudin. 
Danaparoid is pharmacologically 
classified as a low molecular weight 
heparinoid, and is a glycosamino-
glycuronan composed of heparan sulfate 
(84 %) , dermatan sulfate (12%) and 
chondroitin sulfate ( 4%). In the US 
danaparoid is FDA indicated only for DVT 
prophylaxis following elective hip 
replacement surgery, but danaparoid has 
been used extensively in HIT management 
in a Worldwide Compassionate Use case 
series (Magnani HN. Platelets 1997;8:74-81.). 
Danaparoid' s primary anticoagulant 
mechanism includes action as a catalyst 
inactivating factor Xa. Subsequently, the 
anti-Xa effects inhibit thrombin formation, 
and inhibit fibrin and thrombus generation. 
This occurs with only minor effects on 
platelet function and aggregability. 
The activity of danaparoid is measured by 
anti-Xa levels. Maximal anti-Xa activity 
occurs in 2-5 hours, ·but the half life (T1a) 
for anti-Xa effects ranges from 19.2-24.5 
hours in normal renal function. Renal 
elimination accounts for 40-50% of drug 
elimination, and the method of elimination 
for the remainder of drug is unknown. 
Anti-Xa level monitoring is not needed for 
all patients, but is required in the 
following patient populations -- > < 55kg; 
> 90kg; renal or hepatic failure; 
hemodialysis, hemofl1.tration. Additional 
laboratory testing for danaparoid may 
include checking for potential cross-
reactivity to HIT antibodies. Danaparoid 
may have cross-reactivity with IDT 
antibodies ranging from 0-20%. Clinical 
experience to date indicates that 
danaparoid therapy may be initiated safely 
... 
before cross- reactivity testing is done. 
The Worldwide Compassionate Use non-
blinded case series, reporting 584 
evaluable episodes with 462 TEC, 
represents the only published clinical· data 
for the use of danaparoid in HIT therapy. 
(Magnani HN. Platelets 1997;8:74-81.) In this 
case series successful outcome was defmed 
as: platelet recovery, controlled (TEC), 
no new TEC, and no treatment with-
drawal. Platelet recovery occurred in 91%, 
m,d successful treatment in 93%, while 9 
patients ( 1. 7%) had recurrent TEC during 
danaparoid therapy. The authors report 
only serious adverse effects from the case 
series which included bleeding (3 .1 %, 
only life threatening bleeds reported), 
persistent reduced platelet count (2. 6%), 
and skin rash (0.9%). The overall six 
. week mortality was 17.1%. 
There are several dosing regimens for 
danaparoid, depending on the rationale for· 
anticoagulation; age of the thrombus; and 
r~:f.nal status. For specific dosing 
information, please contact the clinical 
pharmacy office (x8884), or refer to the 
citation- Wilde MI, Markham A. Drugs 
1997;54:903-924. Please see table below 
for advantages, disadvantages, and cost 
comparison to Lepirudin. 
The second HIT agent added to the L VH 
formulary, Lepirudin, is recombinant 
hirudin, modeled from the natural product-
leech Hirudo medicinalis. The only US 
product FDA approved for use in HIT, 
~pirudin carries the FDA Indication for: 
Anticoagulation in patients with HIT & 
associated thromboembolic disease to 
prevent further TEC. Pharmacologically 
lepirudin is classified as a direct thrombin 
inhibitor. The drug acts via 1:1 binding 
with thrombin to inhibit thrombogenic 







antithrombin 111, and without neutralization 
by platelet factor 4. This drug alters all 
thrombin dependent coagulation assays, 
and exhibits dose dependent increases in 
aPTT. As a result, therapy is monitored 
using aPTT. The aPTT ratio goal during 
lepirudin therapy is 1.5-2.5 x control. 
Lepirudin acts rapidly, with a terminal half 
life of 1.3 hours. The primary route of 
elimination is renal. The T 112 in renal 
impairment may be increased up to 2 days, 
necessitating extensive dosing adjustments 
Clinical studies in HIT include two multi-
center, prospective, open label, historical 
control trials- HATl (Greinacher et al. 
Circulation 1999;99:73-80), and HAT2 
(currently published only in abstract form 
and as data on me with Hoechst Marion 
Roussel). For the 79 subjects in HAT1 
and the 98 subjects in HAT2, study results 
were as follows: Pit recovery ranged from 
86% - 92%; 74-77% showed effective 
aPTT response; and TEC + Death + 
Amputation =18% (HAT1, n=8,3,6 
respectively) vs 28% (HAT2, n=20,10,11, 
ADVANTAGES DISADV ANI AGES 
respectively). No deaths were due to 
lepirudin. In comparison with historical 
controls, lepirudin showed significantly 
less TEC + Death + Amputation on days 
7 and 35 in HAT1, but in HAT2 
differences did not reach statistical 
significance. The authors noted bleeding 
to be the most common adverse effect 
[HATi- 32.9% had at least 1 event 
(13.4% major bleeds), HAT2- 48% had 
major or minor bleeding]. 
There are very specific guidelines for 
dosing and monitoring lepirudin therapy. 
Dosing depends on the presence or 
absence of TEC, use of thrombolytic 
therapy, and presence of renal dysfunction. 
Guidelines are specific for aPTT 
monitoring, resultant dosing adjustments, 
and conversion to oral anticoagulants. For 
more specific information on dosing and 
monitoring please contact the clinical 
pharmacy office (x8884). Please refer to 
the. attached table for therapeutic 
advantages, disadvantages, and LVH cost 
compared to danaparoid. 
LVHCOST 
Danaparoid -Rapid anticoagulation 
-Experience in large 
-0-20% cross-reactivity 
to HIT antibodies 






- Anti-Xa monitoring not 
necessary in all patients 
-More extensive clinical 
experience than lepirudin 
- Anti-Xa monitoring is 
possible at L VH 




-No cross-reactivity w/ 
HIT antibodies 
- aPTT monitoring 
readily available 
-Srudied as MC, 
historical control data 
-Only agent FDA 
indicated for HIT therapy, 
a potential medical legal 
issue to not carry. 
- Anti-Xa monitoring using 
curve calibrated w/ danaparoid 
difficult from lab perspective 
-No antidote for bleeding 
- Tl/2 long if surgery/procedure 
needed or bleeding occurs 
- Tl/2 extended in renal failure 
but no specific # published or 
known 
-?Greater bleeding risk 
-Accumulation occurs in 
renal impairment 
-No antidote for bleeding 
-? HAT2 results~ trial 
unpublished to date 
Prophyl · 2065 
Danap. -1062 5514367 
Inf. HIT 
Therapy 
LVH cost per unit= $98.36 per 
750aXaU/0.6ml 
Dose Day1$ Dav2-$$/Week 
















The Sixth Annual Update on 
Heart and Lung Surgety 
will be held on Saturday, 
April10, 1999 in theLVH 
Cedar Crest Auditorium. 
The program will: 
- Describe and discuss new procedures and 
technology in cardiothoracic surgery, 
- Compare off-pump beating heart versus 
port-access coronary artery bypass surgery, 
- Discuss the new endoscopic approach to · 
lobectomy, 
- Review advanced mechanical support for 
the failing heart, and 
- Examine the early results on the new 
stentless biological aortic valve. 
For more information or to register, please 
contact Bonnie Schoeneberger via Email or 
phone at (610) 402-1210. · 
If you plan to attend the Update, you and a 
guest are cordially invited to attend a 
cocktail reception honoring the visiting 
professors on April 9, 1999 7-10 pm at the 
John and Dorothy Morgan Cancer Center's 
Kelly Gallagher Atrium. Please RSVP to 
Bonnie Schoeneberger. 
Continuing Education: 
See the following calendar for grand rounds 
and tumor boards. 
I 
News from the Library 
National Library Week is 
April 11th - 17th. 
OVIDI.PubMed TRAINING. 
To schedule one-on-one OVID (MEDLINE) 
training session, call Barbara Iobst in the 
Health Sciences Library at 402-8408. 
Barbara can also instruct you in the use of 
PubMed, a free, Web-based MEDLINE 
service offered by the National Library of 
Medicine (NLM). :MEDLINE can be 
searched directly using PubMed. 
Library Book Order 
The Health Sciences Library is preparing its 
fiscal year-end book order and is seeking 
input from the medical staff. Please E-mail 
Barbara lobst, Director ofLibrary Services, 
with your recommendations. If you prefer 
to call, her extension is 402-8408. 
New Publications - Muhlenbem Hosoital 
Center. 
"Comprehensive Neurology," 2nd edition 
Author: R Rosenberg, et al. 
Call No. WL 100 C737 1998 
New Books- Cedar Crest & 1-78. 
"Hematology/Oncology Clinics ofNorth 
America" Topic: "Current Therapeutic 
Issues in Gynecologic Cancer" Volume 13, 
No. I -February, I999 
Page23 
"The Medical Clinics ofNorth America" 
Topic: "Parkinson's Disease and 
Parkinsonian Syndromes" 
Guest Editor: M Stem, et al. 
Volume 83, No.2- March, 1999. 
New Boolq - 17th & Chew. 
"Seminars in Perinatology" 
Topic: "Current and Evolving Concepts in 
Preeclampsia" 
Guest Editor: G. Saade 
Volume 23, No. 1 -February, 1999 
"Current Problems in Obstetrics, 
Gynecology, and Fertility" 
Topic: "Fetal Telemedicine: Its Role in 
Obstetric Ultrasonography" 
Guest Editor: F. Malone, et al. 
Volume 22, No. 1- January/February, 1999. 
News from the Office of 
Educational Technology 
PC Basics, Windows NT/95 & Eman: 
The following classes will be held at 
Muhlenberg Hospital Center in the liS 
Training Room off the lobby of the main 
building. Please call317-4771 to register. 
Registration is required. 
PC Basics 
April9 - 9-llam 
April 23 - 9-llam 
Windows NT/95 
April9 ·- 1-3pm 





Computer-Based Training <CBD: 
CBT is replacing instructor-led classes 
previously held at L VH. A proctor will be 
in the room with the learner while slhe takes 
the CBT, but the learner will control the 
pace and objectives of the learning. 
Topics covered by CBT include: 





PHAMIS Lastword Inquiry only commands 
E-mail GUI 
CBT takes place in JDMCC, Suite 401. 
From April through December 1999, there 
will be two CBT sessions every Tuesday. 
The morning session is 8:00 am to noon. 
The afternoon session is 12:30 to 4:30 pm. 
( 
Twelve slots are available for each session ( 
To register, please contact Bonnie 
Schoeneberger via email or at 402-1210. 
If you have questions regarding CBT, please 
contact Craig Koller via email or at 402-
1427. 
Ally ~. concems or COfrllllerlll on articles from C£DS, 
pleau CGflflrct Sllllk UTfler 402-1403 
,,..-~. 
... ltd l'raf• lill 
Grand Round and 
Tumor Board Schedule 
SUNDAY MoNDAY 
4 12 Noon CIR Tumor Board 
- JDMCC - CR1 AlB 
II 
18 12 Noon CIR Tumor Board 
- J0MCC • CR1 AlB 
25 
TUESDAY 
5 7 am Surglcel Grand 
RIIIIIMk - CC-Aud -
lam PediatriC G111nd 
Rounds- 17-Aud 
12 Noon Medical Grand 
Rounds CC-Aud 
12 7em Ambulatory CBn 
Guideline Dev- SON 
7 am Surgical G111nd 
Rounds- CC-Aud-
lam PediatriC G111nd 
Rounds- 17-Aud 
12 Noon Medical G111nd 
Rounds CC-Aud 
19 7 am Surgical Grand 
Rounds- CC-Aud • 
8am PediatriC G111nd 
Rounds -17-Aud 
12 Noon Medical Gl1lnd 
Rounds CC-Aud 
26 7 am stahler /Rex 
Sym~um-CC-Aud-
8am Pediatric G111nd 
Rounds - 17-Aud 
12 Noon Medical G111nd 
Rounds CC-Aud 
12 Noon Urology Tumor 





8 am Emergency 
Medicine Grand Rounds-
12S1SCC, Suite 308C 
12 Noon Combined 
Tumor Board- JDMCC-
CR1AIB 
6 7 12 Noon Gl Tumor Board 
- JDMCC- CR1 AlB 
D 12 Noon Pulmonary Tumor 14 12 Noon Cancer 
Board - JDMCC- CR1 AlB Committee- JDMCC-
CR1AIB 
20 11 12 Noon Combined 
Tumor Board- JDMCC -
CR1AIB 
17 18 12 Noon Combined 
Tumor Board - JDMCC -
CR1AIB 
FRIDAY 
I 7 am GVN Tumor 
BoardiOBGVN Grand 
Rounds - 17 Aud 
12 Noon 8.-t Tumor 
Board- JDMCC.. CR1 AlB 
1 7am OBGVN G111nd 
Rounds -17 Aud 
12 Noon Pediatric Noon 
Conf-17Aud 
12 Noon Brast Tumor 
Board- JDMCC.. CR1 AlB 
IS 7am OBGVNG111nd 
Rounda -17 Aud 
12 Noon 8.-t Tumor 
Board- JOMCC- CR1 AlB 
n 7em OBGVN G111nd 
Rounda -17 Aud 
12 Noon Pediatric Noon 
Conf-17Aud 
12 Noon Breast Tumor 
Board - JDMCC. CR1 AlB 
19 7am OBGVN G111nd 
Rounds -17 Aud 
12 Noon Br.at Tumor 




Update on Heart 
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Permit No. 19 
Medical Staff Progress Notes 
is published monthly to 
inform the Medical Staffs of 
Lehigh Valley Hospital and 
Muhlenberg Hospital Center 
and employees of important 
issues concerning the 
Medical Staffs. 
Articles should be submitted 
to Janet M. Seifert, Physician 
Relations, Lehigh Valley 
Hospital, Cedar Crest & 1·78, 
P.O. Box 689, Allentown, PA 
18105-1556, by the 15th of 
each month. If you have any 
questions about the 
newsletter, please call Mrs. 
Seifert at 402-8590. 
( 
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